Key result
Muscle channelopathies are rare disorders where a high index of suspicion and knowledge of the phenotype help guide neurophysiological and genetic testing to assist in avoiding triggers and directing treatments.
Why the study?
Muscle channelopathies are rare, heterogeneous disorders that can be clinically challenging and functionally disabling in adult and pediatric populations.
A comprehensive review of muscle channelopathies highlighting the importance of neurophysiological and genetic testing for accurate diagnosis and targeted management.
Answers are grounded in this paper and cite their sources.
May support neurophysiologic/genetic testing for channelopathy diagnosis; leaves open prospective validation of treatments.
Background: Muscle channelopathies are a rare and heterogeneous group of disorders that can be clinically challenging and functionally disabling. These disorders can present in both adult and pediatric age groups. These disorders have been known since the turn of the 20th century, with a steady evolution in terms of understanding the pathophysiology, phenotype, diagnostic, and treatment modalities over the last three decades. Methods: We present a comprehensive review of muscle channelopathies that includes nondystrophic myotonias and periodic paralyses. The disorders in this review have been classified based on the presence or absence of myotonia on either the clinical exam or on electrophysiological testing. The historical background, genetics, pathophysiology, phenotypic presentations, and treatment modalities of each disorder reveal similarities as well as specific nuances in the disease phenotypes. Neurophysiologic testing shows differences in responses on routine and exercise testing and can narrow the differential within subsets of nondystrophic myotonias and periodic paralyses. The advances in genetics further aid in specifying which of the putative channels are at fault. Management can then be guided by knowledge of the causative gene and involves either avoidance of triggers or channel-based therapeutics. Conclusion: Muscle channelopathies are rare, but a high index of suspicion along with a knowledge of the phenotype will help guide neurophysiological and genetic testing. A muscle channelopathy diagnosis, subsequently, can assist in avoiding triggers and directing treatments.
No takes yet. Share an insight, caveat, or question.
McGowan et al. (2023) conducted a review in Muscle channelopathies. Muscle channelopathies are rare disorders where a high index of suspicion and knowledge of the phenotype help guide neurophysiological and genetic testing to assist in avoiding triggers and directing treatments.
Synapse has enriched 10 related papers. Consider them for comparative context: